SIRAL1

gene
On this page

Also known as SIRalFLJ21103

Summary

SIRAL1 (SIR2 antiphage like 1, HGNC:26110) is a protein-coding gene on chromosome 11q24.2, encoding Protein FAM118B (Q9BPY3). May play a role in Cajal bodies formation.

Enables identical protein binding activity. Predicted to be located in Cajal body.

Source: NCBI Gene 79607 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 49 total
  • MANE Select transcript: NM_024556

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26110
Approved symbolSIRAL1
NameSIR2 antiphage like 1
Location11q24.2
Locus typegene with protein product
StatusApproved
AliasesSIRal, FLJ21103
Ensembl geneENSG00000197798
Ensembl biotypeprotein_coding
OMIM616587
Entrez79607

Gene structure

Transcript identifiers

Ensembl transcripts: 31 — 28 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000360194, ENST00000525338, ENST00000525728, ENST00000527247, ENST00000528985, ENST00000529731, ENST00000530043, ENST00000531935, ENST00000533050, ENST00000627851, ENST00000891477, ENST00000891478, ENST00000891479, ENST00000891480, ENST00000891481, ENST00000891482, ENST00000891483, ENST00000891484, ENST00000891485, ENST00000891486, ENST00000933494, ENST00000933495, ENST00000933496, ENST00000933497, ENST00000933498, ENST00000933499, ENST00000933500, ENST00000942845, ENST00000942846, ENST00000942847, ENST00000942848

RefSeq mRNA: 2 — MANE Select: NM_024556 NM_001330446, NM_024556

CCDS: CCDS81647, CCDS8470

Canonical transcript exons

ENST00000533050 — 9 exons

ExonStartEnd
ENSE00000991269126254305126254433
ENSE00000991270126256567126256852
ENSE00000991271126261425126261484
ENSE00001203239126229225126229293
ENSE00002175106126262120126262968
ENSE00002177170126211782126211830
ENSE00003555205126234995126235087
ENSE00003565323126250506126250733
ENSE00003649190126240792126241044

Expression profiles

Bgee: expression breadth ubiquitous, 246 present calls, max score 94.16.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.7891 / max 270.0191, expressed in 1797 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
11748915.31111797
1174880.4780275

Top tissues by expression

253 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oocyteCL:000002394.16gold quality
secondary oocyteCL:000065594.16gold quality
mucosa of sigmoid colonUBERON:000499391.42gold quality
colonic mucosaUBERON:000031791.29gold quality
rectumUBERON:000105290.80gold quality
mucosa of transverse colonUBERON:000499190.38gold quality
cortical plateUBERON:000534389.48gold quality
tendon of biceps brachiiUBERON:000818889.44gold quality
ileal mucosaUBERON:000033189.24gold quality
heart right ventricleUBERON:000208088.65gold quality
monocyteCL:000057688.55gold quality
nucleus accumbensUBERON:000188288.55gold quality
medial globus pallidusUBERON:000247788.53gold quality
caudate nucleusUBERON:000187388.34gold quality
leukocyteCL:000073888.24gold quality
deltoidUBERON:000147688.04gold quality
gastrocnemiusUBERON:000138887.88gold quality
transverse colonUBERON:000115787.76gold quality
muscle of legUBERON:000138387.71gold quality
putamenUBERON:000187487.70gold quality
islet of LangerhansUBERON:000000687.00gold quality
smooth muscle tissueUBERON:000113586.91gold quality
stromal cell of endometriumCL:000225586.75gold quality
heart left ventricleUBERON:000208486.74gold quality
pancreatic ductal cellCL:000207986.63silver quality
cardiac ventricleUBERON:000208286.62gold quality
left ventricle myocardiumUBERON:000656686.53gold quality
epithelial cell of pancreasCL:000008386.39gold quality
large intestineUBERON:000005986.37gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.30gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-110499no195.63
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

77 targeting SIRAL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-3646100.0073.565283
HSA-MIR-3924100.0072.092394
HSA-MIR-3120-5P100.0065.56965
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-539-5P99.9370.302855
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-129799.9173.413162
HSA-MIR-10523-5P99.9169.222038
HSA-MIR-380-3P99.8970.181978
HSA-MIR-548D-3P99.8770.674362
HSA-MIR-806799.8669.592260
HSA-MIR-221-5P99.8665.451052
HSA-MIR-807399.8665.211118
HSA-MIR-548BB-3P99.8670.584354
HSA-MIR-548AR-3P99.8571.263889
HSA-MIR-548AC99.8470.774351
HSA-MIR-548H-3P99.8470.804349
HSA-MIR-548Z99.8470.804349
HSA-MIR-132399.8369.892471
HSA-MIR-449599.8272.083080
HSA-MIR-548AZ-3P99.8270.563549
HSA-MIR-548BC99.8270.613524
HSA-MIR-548E-3P99.8270.593514
HSA-MIR-548F-3P99.8270.593540

Literature-anchored findings (GeneRIF, showing 1)

  • YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas. (PMID:33074854)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriofam118bENSDARG00000078983
mus_musculusFam118bENSMUSG00000050471
rattus_norvegicusFam118bENSRNOG00000011543

Paralogs (1): FAM118A (ENSG00000100376)

Protein

Protein identifiers

Protein FAM118BQ9BPY3 (reviewed: Q9BPY3)

All UniProt accessions (6): E9PIM5, E9PMJ2, E9PMW3, G3V179, J3KP39, Q9BPY3

UniProt curated annotations — full annotation on UniProt →

Function. May play a role in Cajal bodies formation.

Subcellular location. Nucleus. Cajal body.

Miscellaneous. Overexpression changes the morphology of Cajal bodies, while depletion disrupts the localization of components of Cajal bodies, reduces splicing capacity and inhibits cell proliferation.

Similarity. Belongs to the FAM118 family.

RefSeq proteins (2): NP_001317375, NP_078832* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR038916FAM118Family

Pfam: PF13289

UniProt features (5 total): modified residue 2, initiator methionine 1, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

3 structures.

PDBMethodResolution (Å)
9R0PELECTRON MICROSCOPY4.1
9R3EELECTRON MICROSCOPY4.8
9R0SELECTRON MICROSCOPY5

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BPY3-F184.660.64

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 2, 9

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 125 (showing top): GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, TGGNNNNNNKCCAR_UNKNOWN, RASHI_RESPONSE_TO_IONIZING_RADIATION_5, GOCC_CAJAL_BODY, GOCC_NUCLEAR_BODY, GOCC_RIBONUCLEOPROTEIN_GRANULE, chr11q24, CAGTATT_MIR200B_MIR200C_MIR429, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN, LEE_BMP2_TARGETS_DN, GOCC_SUPRAMOLECULAR_COMPLEX, ESC_J1_UP_EARLY.V1_DN, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP, GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN

GO Biological Process (0):

GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (2): Cajal body (GO:0015030), nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein binding1
binding1
nuclear ribonucleoprotein granule1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

1127 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SIRAL1MAMLD1Q13495815
SIRAL1ZFTAC9JLR9808
SIRAL1YAP1P46937572
SIRAL1NUTM1Q86Y26451
SIRAL1INTS4Q96HW7446
SIRAL1PRKG1P14619435
SIRAL1RELAQ04206411
SIRAL1MAML2Q8IZL2409
SIRAL1EZHIPQ86X51383
SIRAL1TFE3P19532368
SIRAL1TMEM185BQ9H7F4360
SIRAL1CAMTA1Q9Y6Y1356
SIRAL1MAML3Q96JK9346
SIRAL1RHBDD3Q9Y3P4332
SIRAL1TRMOQ9BU70320

IntAct

101 interactions, top by confidence:

ABTypeScore
VAPBFAM83Gpsi-mi:“MI:0914”(association)0.730
FAM118AFAM118Bpsi-mi:“MI:0915”(physical association)0.720
FAM118BFAM118Apsi-mi:“MI:0915”(physical association)0.720
SCN2BEXOC5psi-mi:“MI:0914”(association)0.640
TOMM22XRCC3psi-mi:“MI:0914”(association)0.640
FAM118BSDCBPpsi-mi:“MI:0915”(physical association)0.560
SUMO1P1FAM118Bpsi-mi:“MI:0915”(physical association)0.560
SUMO1FAM118Bpsi-mi:“MI:0915”(physical association)0.560
FAM118BBAG5psi-mi:“MI:0915”(physical association)0.560
SDCBPFAM118Bpsi-mi:“MI:0915”(physical association)0.560
BAG5FAM118Bpsi-mi:“MI:0915”(physical association)0.560
FAM118BSUMO1psi-mi:“MI:0915”(physical association)0.560
RNF8FAM118Bpsi-mi:“MI:0915”(physical association)0.560
FAM118BFAM118Bpsi-mi:“MI:0915”(physical association)0.560
FAM118BRAD54L2psi-mi:“MI:0915”(physical association)0.560
PIAS2FAM118Bpsi-mi:“MI:0915”(physical association)0.560
FAM118BPDCD10psi-mi:“MI:0915”(physical association)0.560
FAM174ABLTP3Bpsi-mi:“MI:0914”(association)0.530

BioGRID (101): FAM118B (Two-hybrid), FAM118B (Two-hybrid), FAM118B (Two-hybrid), FAM118B (Two-hybrid), SUMO1P1 (Two-hybrid), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS), FAM118B (Affinity Capture-MS)

ESM2 similar proteins: A0A0M5K865, A0A0P0VUY4, A0A2H5RJD4, A0A447CCJ8, A0A516F180, A0A516F183, B1Q3J6, B2AFA8, C0SQ89, E9M7A1, F4K493, G4YRT1, G4YUT3, O93248, P0CV73, P15918, P15919, P24271, P26358, P34088, P93002, Q0E0Q3, Q24K09, Q2M3Z7, Q2M3Z8, Q2M405, Q2M408, Q67E00, Q67E01, Q6RX08, Q7Y1I7, Q803H0, Q867B5, Q8AXQ3, Q8BMD7, Q8C569, Q8CBQ5, Q8H6Z4, Q8H6Z6, Q8LPU5

Diamond homologs: Q4QQT2, Q4R836, Q5E977, Q8C569, Q91YN1, Q9BPY3, Q9NWS6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

49 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance36
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1635 predictions. Top by Δscore:

VariantEffectΔscore
11:126229333:T:Gdonor_gain1.0000
11:126234991:TTAG:Tacceptor_loss1.0000
11:126234992:TA:Tacceptor_loss1.0000
11:126234993:A:AGacceptor_gain1.0000
11:126234993:A:ATacceptor_loss1.0000
11:126234994:G:GGacceptor_gain1.0000
11:126241041:TCCT:Tdonor_gain1.0000
11:126241045:G:GGdonor_gain1.0000
11:126250504:A:AGacceptor_gain1.0000
11:126250505:G:GGacceptor_gain1.0000
11:126250505:GC:Gacceptor_gain1.0000
11:126250730:AAAG:Adonor_loss1.0000
11:126250731:AAGG:Adonor_loss1.0000
11:126250732:AG:Adonor_loss1.0000
11:126250733:GGTAA:Gdonor_loss1.0000
11:126256564:CA:Cacceptor_loss1.0000
11:126256565:A:ACacceptor_loss1.0000
11:126256565:A:AGacceptor_gain1.0000
11:126256566:G:GAacceptor_gain1.0000
11:126256566:GA:Gacceptor_gain1.0000
11:126256566:GAGA:Gacceptor_gain1.0000
11:126256852:GG:Gdonor_loss1.0000
11:126256853:G:GAdonor_loss1.0000
11:126256854:T:Adonor_loss1.0000
11:126262119:GGCT:Gacceptor_gain1.0000
11:126229273:G:GTdonor_gain0.9900
11:126231166:T:Aacceptor_gain0.9900
11:126234994:GA:Gacceptor_gain0.9900
11:126234994:GAAA:Gacceptor_gain0.9900
11:126235083:CCCAG:Cdonor_loss0.9900

AlphaMissense

2313 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:126240848:G:AG48E1.000
11:126240898:T:AW65R1.000
11:126240898:T:CW65R1.000
11:126240900:G:CW65C1.000
11:126240900:G:TW65C1.000
11:126241016:C:AA104D1.000
11:126241025:T:CL107P1.000
11:126250655:T:AN163K1.000
11:126250655:T:GN163K1.000
11:126240809:T:CL35S0.999
11:126240847:G:AG48R0.999
11:126240847:G:CG48R0.999
11:126240848:G:TG48V0.999
11:126240854:G:AG50D0.999
11:126240859:A:CS52R0.999
11:126240861:T:AS52R0.999
11:126240861:T:GS52R0.999
11:126240899:G:CW65S0.999
11:126241037:T:CL111P0.999
11:126250648:C:TT161I0.999
11:126250659:G:CD165H0.999
11:126250660:A:CD165A0.999
11:126250660:A:TD165V0.999
11:126254314:T:AW193R0.999
11:126254314:T:CW193R0.999
11:126254347:C:GH204D0.999
11:126254357:G:AG207E0.999
11:126256606:T:CF246L0.999
11:126256607:T:CF246S0.999
11:126256608:C:AF246L0.999

dbSNP variants (sampled 300 via entrez): RS1000001988 (11:126211625 C>T), RS1000037247 (11:126231419 T>C), RS1000108868 (11:126257842 C>A), RS1000176021 (11:126239425 G>A), RS1000207768 (11:126246573 C>G,T), RS1000211101 (11:126250274 G>A), RS1000297544 (11:126217872 T>C), RS1000374053 (11:126244551 C>A), RS1000419633 (11:126253374 G>C,T), RS1000431926 (11:126236862 G>A), RS1000456607 (11:126257366 A>G), RS1000483971 (11:126238139 A>G), RS1000547841 (11:126239780 C>T), RS1000636636 (11:126229487 A>G), RS1000724092 (11:126244213 G>A)

Disease associations

OMIM: gene MIM:616587 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression3
Acetaminophenincreases expression2
Hydrogen Peroxideaffects expression, increases expression2
dicrotophosdecreases expression1
trichostatin Aaffects expression1
beta-lapachoneincreases expression1
potassium chromate(VI)affects cotreatment, decreases expression1
cupric chlorideincreases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
di-n-butylphosphoric acidaffects expression1
Bortezomibincreases expression1
Air Pollutants, Occupationaldecreases expression1
Doxorubicindecreases expression1
Nickeldecreases expression1
Testosteronedecreases expression1
Tretinoindecreases expression1
Cyclosporineincreases expression1
Aflatoxin B1increases methylation1
Cadmium Chloridedecreases expression1
Copper Sulfatedecreases expression1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.